Get the Stockscreener App
0.00
100.00%
-2.09
After Hours:
2.10
2.10
+
Hillevax Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
See More
Previous Close:
$2.09
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$104.76M
Revenue:
-
Net Income/Loss:
$-123.57M
P/E Ratio:
0.00
EPS:
-3.04
Net Cash Flow:
$-97.53M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$2.17
Hillevax Inc Stock (HLVX) Company Profile
Name
Hillevax Inc
Sector
Industry
Phone
(617) 213-5054
Address
321 HARRISON AVE, SUITE 500, BOSTON
Compare HLVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HLVX
Hillevax Inc
|
0.00 | 104.76M | 0 | -123.57M | -97.53M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hillevax Inc Stock (HLVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-09-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-09-24 | Downgrade | Stifel | Buy → Hold |
| Jul-08-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-23 | Initiated | H.C. Wainwright | Buy |
View All
Hillevax Inc Stock (HLVX) Latest News
Sudo Biosciences Appoints Paul Bavier as Chief Legal Counsel - Business Wire
Is HilleVax Inc. stock attractive for retirement portfolios2025 Earnings Impact & Precise Swing Trade Alerts - Newser
Aug EndMonth: Why HilleVax Inc stock could see breakout soonWeekly Stock Recap & Intraday High Probability Setup Alerts - BỘ NỘI VỤ
Can HilleVax Inc. stock sustain institutional interestGap Down & Stock Portfolio Risk Management - moha.gov.vn
Is NIIT Learning Systems Limited on Track for Record Quarterly RevenueEx-Dividend Date Alerts & Low Risk Investment Tips - earlytimes.in
Why HilleVax Inc. stock could outperform in 2025Oil Prices & Weekly Watchlist of Top Performers - newser.com
Is HilleVax Inc. stock a top momentum playQuarterly Portfolio Report & Verified High Yield Trade Plans - newser.com
Is HilleVax Inc. stock cheap at current valuationWeekly Trade Review & Verified Technical Signals - newser.com
Is HilleVax Inc. stock a buy in volatile markets2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
What to expect from HilleVax Inc. in the next 30 daysWeekly Risk Summary & Capital Efficient Trading Techniques - newser.com
Will HilleVax Inc. see short term momentumTrade Risk Assessment & Capital Efficiency Focused Ideas - newser.com
Pattern recognition hints at HilleVax Inc. upsideMarket Performance Report & Real-Time Market Sentiment Alerts - newser.com
Is HilleVax Inc. trending in predictive chart modelsEarnings Beat & Target Return Focused Stock Picks - newser.com
How to use a screener to detect HilleVax Inc. breakouts2025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - newser.com
Will HilleVax Inc. stock recover faster than marketPortfolio Performance Report & Long-Term Capital Growth Strategies - newser.com
HilleVax Inc Stock Analysis and ForecastCapital Gains Strategies & Free Quantitative Trading Strategies - earlytimes.in
Can HilleVax Inc. stock resist market sell offsJuly 2025 Technicals & Fast Moving Trade Plans - newser.com
What technical signals suggest for HilleVax Inc. stock2025 Earnings Surprises & Proven Capital Preservation Methods - newser.com
Predicting HilleVax Inc. trend using moving averagesJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
XOMA Royalty Reports Third Quarter and Year to Date 2025 - GlobeNewswire
XOMA Royalty Corporation Reports Financial Results and Business Developments for Q3 2025, Including Key Acquisitions and Pipeline Updates - Quiver Quantitative
What sentiment indicators say about HilleVax Inc. stock2025 Geopolitical Influence & AI Enhanced Trading Signals - newser.com
Is it time to cut losses on HilleVax Inc.2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
What the charts say about HilleVax Inc. todayTreasury Yields & Fast Exit and Entry Trade Guides - newser.com
How HilleVax Inc. stock reacts to Fed rate cutsJuly 2025 Recap & AI Based Trade Execution Alerts - newser.com
Hillevax Inc Stock (HLVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):